# Haloperidol

## Haldol inj 5mg/1mL

| 藥物代碼 | IHALD |
| :--- | :--- |
| 適應症 | Acute psychosis ,Nausea and vomiting, Restlessness and confusion |
| 副作用 | Tardive dyskinesia; extrapyramidal reactions. Anxiety, drowsiness, depression, anorexia, transient tachycardia, postural hypotension, leukopenia; anticholinergic side effects. |
| 禁忌 | Severe toxic CNS depression; preexisting coma; Parkinson's disease; lactation |
| 藥物保存方式 | 室溫 |
| 用法用量 | Intramuscular Acute psychosis Adult: Doses range from 2-10 mg, may be given every hr or at intervals of 4-8 hr, until symptoms are controlled. Max: 18 mg/day. For emergency control of severely disturbed patients: Up to 18 mg may be given IM. Intramuscular  Nausea and vomiting  Adult: 0.5-2 mg daily. In palliative care, 1.5 mg 1-2 times daily via oral admin or 2.5-10 mg over 24 hr by SC infusion \(via a syringe driver\). Subcutaneous  Restlessness and confusion  Adult: 5-15 mg via SC infusion over 24 hr. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest moderate risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity 無\(很少\)資料 - 避免使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

